Skip to content

Medical-device intelligence

QHA: X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device

FDA product code QHA: X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QHA
FDA device name
X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
Device class
2
Regulation number
892.1600
Medical specialty
Radiology
Review panel
RA

FDA definition

X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology applications. X-ray angiographic imaging based coronary vascular simulation software device cannot be used alone for clinical decision making and clinical management, and is a tool intended to generate results for use and review by a qualified clinician.
Explore radiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

7 clearance records and 0 recall records in the covered releases, across 5 source company names and 1 product codes. Dated history runs from May 30, 2019 to Oct 17, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202510
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

7 matching records
Device / recordCompany in FDA recordSourceSource date
X1-FFRK251355 · QHASpectrawave, Inc.510(k)Oct 17, 2025FDA decision date
QFR (3.0)K243769 · QHAQfr Solutions BV510(k)Apr 4, 2025FDA decision date
CAAS WorkstationK232147 · QHAPie Medical Imaging BV510(k)Apr 9, 2024FDA decision date
AccuFFRangio PlusK230303 · QHAArteryFlow Technology Co., Ltd.510(k)Mar 2, 2023FDA decision date
AccuICASK221711 · QHAArteryFlow Technology Co., Ltd.510(k)Feb 28, 2023FDA decision date
AccuFFRangioK210093 · QHAArteryFlow Technology Co., Ltd.510(k)Sep 10, 2021FDA decision date
Qangio XA 3DK182611 · QHAMedis Medical Imaging Systems BV510(k)May 30, 2019FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗